OPKO Health
Manufacturing · Florida, United States · 3,930 Employees
View Company Info for Free
About
Headquarters
4400 Biscayne Blvd, Miami, Florida, 33137, Unit...Phone Number
(305) 575-4100Website
www.opko.comRevenue
$716.4 MillionStock Symbol
OPKIndustry
Most Recent Scoops
Highlights
$62.3M
Total Funding Amount
$62.3M
Most Recent Funding Amount
1
Number of Funding Rounds
Who is OPKO Health
Established in 2007 and headquartered in Miami, Florida, OPKO Health is a medical test and medication company specializes in diagnostics and pharma ceuticals.Read more
Popular SearchesOpko Health IncOpko HealthOPKO Lab LLCOpko Pharmaceuticals LLCOpko Health LLCSIC Code 28,283NAICS Code 32,325Ticker NASDAQ: OPKShow moreOPKO Health Org Chart
Is OPKO Health your ideal customer?
Let us give you the heads up on whether it's a good time to reach out
Check out if OPKO Health is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at OPKO Health
Check if OPKO Health has recently received funding, and reach out quickly before it becomes old news!
Click to see if OPKO Health had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once OPKO Health has new funding data
Earning: See what the market has to say on OPKO Health recently announced quarterly report
Product Launch: Get notified when OPKO Health launches new products
Website visits: Recent activity has been detected on your website
OPKO Health, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Similar Companies to OPKO Health
Analyze insights from companies similar to OPKO Health and make strategic comparisons based on performance, financial data, growth and unique benchmarks.
- Jazz Pharmaceuticals2,800$3.9B
- Otsuka America Pharmaceutical ...2,000$675.1M
- Takeda Oncology2,315$781.5M
- Myriad Genetics2,700$802.2M
- BioMarin3,401$2.6B
- Amneal Pharmaceuticals7,850$2.5B
- Moderna5,600$5B
- Alexion4,000$6.1B
More similar companies
OPKO Health financials insights
Gather financial insights about OPKO Health, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
OPKO Health Employee Growth Rate
Percentage of growth
1st year Mask
2nd year Mask
OPKO Health Tech Stack
A closer look at the technologies used by OPKO Health
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Most Recent Scoops
OPKO Health News & Media
OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results
Conference call begins at 4:30 p.m. Eastern time today Conference call begins at 4:30 p.m. Eastern time todayOPKO Health to Report Second Quarter 2024 Financial Results on August 7, 2024
MIAMI, Aug. 01, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and six months ended June 30, 2024 after the close of the U.S. financial markets on Wednesday, August 7, 2024. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on August 7th beginning at 4:30 p.m. Eastern time.OPKO Health Announces $100 Million Share Repurchase Program
MIAMI, July 18, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that its Board of Directors has authorized the repurchase of up to $100 million of shares of the Company's common stock. Under the repurchase program, OPKO may repurchase shares of its common stock from time to time through open market purchases, block trades, privately negotiated transactions, accelerated share repurchase transactions and/or pursuant to Rule 10b5-1 plans, in compliance with applicable securOPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA’s Profit Share Payments
MIAMI, July 17, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announces it has entered into a $250 million non-dilutive note purchase agreement with HealthCare Royalty (HCRx) secured by OPKO’s profit share payments from Pfizer received pursuant to its license agreement relating to NGENLA™, a once-weekly treatment currently marketed to treat pediatric growth hormone deficiency.
Frequently Asked Questions Regarding OPKO Health
Established in 2007 and headquartered in Miami, Florida, OPKO Health is a medical test and medication company specializes in diagnostics and pharmaceuticals.... Read More